ConductScience.org, home

Paper12464801

Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.

Innocenti F and 7 others. Pharmacogenetics, 2002. Cited by 141 papers, by iCite.

Cite this record

ConductScience Library. Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups. Papers, record 12464801. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12464801

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.
PubMed
Journal
Pharmacogenetics
PubMed
Year
2002
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
141
iCite
Relative citation ratio, by iCite
3.43
iCite
Revised in PubMed
2026-01-28
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Innocenti FFederico
2Grimsley CCarrie
3Das SSoma
4Ramírez JJacqueline
5Cheng CCheng
6Kuttab-Boulos HHala
7Ratain MJMark J
8Di Rienzo AAnna

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CamptothecinMajor topic
GlucuronosyltransferaseMajor topic
Microsomes, LiverMajor topic
Polymorphism, GeneticMajor topic
Promoter Regions, GeneticMajor topic
Black or African American
Base Sequence
Bilirubin
Genotype
Glucuronides
Haplotypes
Humans
Irinotecan
Linkage Disequilibrium
Molecular Sequence Data
Phenobarbital
Topoisomerase I Inhibitors
White People
UGT1A1 Enzyme

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
GM61393NIGMS NIH HHSUnited StatesU01GM061393PubMed and NIHNIH RePORTER
U01-GM61374NIGMS NIH HHSUnited StatesU01GM061374PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 141 citations.

PMIDTitleJournalYearIn PapersSource
41304835The Association Between Genetic Polymorphisms of UGT1A1, ABCG2, and NR1I2 and Dolutegravir Pharmacokinetic Parameters in Thai People Living with HIV.Pharmaceutics2025https://conductscience.org/library/papers/41304835PubMed
40143136Managing Irinotecan-Induced Diarrhea: A Comprehensive Review of Therapeutic Interventions in Cancer Treatment.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40143136PubMed
38682893Assessing Pharmacogenomic loci Associated with the Pharmacokinetics of Vamorolone in Boys with Duchenne Muscular Dystrophy.J Clin Pharmacol2024https://conductscience.org/library/papers/38682893PubMed
36778023PAnno: A pharmacogenomics annotation tool for clinical genomic testing.Front Pharmacol2023https://conductscience.org/library/papers/36778023PubMed
35942604Bilirubin metabolism and UDP-glucuronosyltransferase 1A1 variants in Asians: Pathogenic implications and therapeutic response.Kaohsiung J Med Sci2022https://conductscience.org/library/papers/35942604PubMed
35205356Pharmacogenetics of Drugs Used in the Treatment of Cancers.Genes (Basel)2022https://conductscience.org/library/papers/35205356PubMed
34860573All You Need to Know About UGT1A1 Genetic Testing for Patients Treated With Irinotecan: A Practitioner-Friendly Guide.JCO Oncol Pract2022https://conductscience.org/library/papers/34860573PubMed
32821392Application of pharmacogenetics in oncology.Biomark Res2020https://conductscience.org/library/papers/32821392PubMed
32019188Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)n Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors?Int J Mol Sci2020https://conductscience.org/library/papers/32019188PubMed
30669780[Clinical diagnosis of genetic liver disease].Zhonghua Gan Zang Bing Za Zhi2018https://conductscience.org/library/papers/30669780PubMed
29520731Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.Clin Pharmacokinet2018https://conductscience.org/library/papers/29520731PubMed
28620445Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment.EPMA J2017https://conductscience.org/library/papers/28620445PubMed
28594959Reduced total serum bilirubin levels are associated with ulcerative colitis.PLoS One2017https://conductscience.org/library/papers/28594959PubMed
28567595Do Alpha Thalassemia, Fetal Hemoglobin, and the UGT1A1 Polymorphism have an Influence on Serum Bilirubin Levels and Cholelithiasis in Patients with Sickle Cell Disease?Mol Diagn Ther2017https://conductscience.org/library/papers/28567595PubMed
28213806Clinical UGT1A1 Genetic Analysis in Pediatric Patients: Experience of a Reference Laboratory.Mol Diagn Ther2017https://conductscience.org/library/papers/28213806PubMed
27978934[The analysis of UGT1A1 gene mutations in hereditary unconjugated hyperbilirubinemia].Zhonghua Gan Zang Bing Za Zhi2016https://conductscience.org/library/papers/27978934PubMed
27767376Pharmacogenomics and histone deacetylase inhibitors.Pharmacogenomics2016https://conductscience.org/library/papers/27767376PubMed
26773202UGT genotyping in belinostat dosing.Pharmacol Res2016https://conductscience.org/library/papers/26773202PubMed
26637161UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation.J Clin Pharmacol2016https://conductscience.org/library/papers/26637161PubMed
26313268Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer.J Clin Pharmacol2016https://conductscience.org/library/papers/26313268PubMed

See all 49 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
UGT1A154658PubTator's text mininghttps://conductscience.org/library/genes/54658

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12464801

GET https://conductscience.org/api/papers/v1/12464801/cited_by?page=2